TrialSignal transduction and targeted therapy2021
The molecular tumor burden index as a response evaluation criterion in breast cancer.
Zongbi Yi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
34 papers cite it
this paperpooled ittrialcites it